Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amphastar Pharmaceuticals (AMPH) Return on Capital Employed (2016 - 2025)

Amphastar Pharmaceuticals (AMPH) has 12 years of Return on Capital Employed data on record, last reported at 0.1% in Q3 2025.

  • For Q3 2025, Return on Capital Employed fell 5.0% year-over-year to 0.1%; the TTM value through Sep 2025 reached 0.1%, down 5.0%, while the annual FY2024 figure was 0.15%, 7.0% down from the prior year.
  • Return on Capital Employed reached 0.1% in Q3 2025 per AMPH's latest filing, down from 0.13% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.18% in Q1 2023 and bottomed at 0.03% in Q1 2021.
  • Average Return on Capital Employed over 5 years is 0.13%, with a median of 0.15% recorded in 2023.
  • Peak YoY movement for Return on Capital Employed: rose 11bps in 2022, then fell -5bps in 2025.
  • A 5-year view of Return on Capital Employed shows it stood at 0.13% in 2021, then surged by 34bps to 0.17% in 2022, then dropped by -10bps to 0.15% in 2023, then fell by -2bps to 0.15% in 2024, then fell by -29bps to 0.1% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Capital Employed were 0.1% in Q3 2025, 0.13% in Q2 2025, and 0.14% in Q1 2025.